Imperial College London

DrLucaMagnani

Faculty of MedicineDepartment of Surgery & Cancer

Principal Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 2808l.magnani CV

 
 
//

Location

 

140ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Patel:2016:10.1158/1078-0432.CCR-15-1104,
author = {Patel, H and Abduljabbar, R and Lai, CF and Periyasamy, M and Harrod, A and Gemma, C and Steel, J and Patel, N and Busonero, C and Jerjees, D and Remenyi, J and Smith, S and Gomm, JJ and Magnani, L and Gyorffy, B and Jones, JL and Fuller-Pace, FV and Shousha, S and Buluwela, L and Rakha, EA and Ellis, IO and Coombes, RC and Ali, S},
doi = {10.1158/1078-0432.CCR-15-1104},
journal = {Clinical Cancer Research},
pages = {5929--5938},
title = {CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer},
url = {http://dx.doi.org/10.1158/1078-0432.CCR-15-1104},
volume = {22},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - PURPOSE: CDK-activation kinase (CAK) is required for the regulation of the cell-cycle and is a trimeric complex consisting of Cyclin Dependent Kinase 7 (CDK7), Cyclin H and the accessory protein, MAT1. CDK7 also plays a critical role in regulating transcription, primarily by phosphorylating RNA polymerase II, as well as transcription factors such as estrogen receptor-alpha(ERalpha).). Deregulation of cell cycle and transcriptional control is aare general featurefeatures of cancertumor cells, highlighting the potential for the use of CDK7 inhibitors as novel cancer therapeutics in cancer. EXPERIMENTAL DESIGN: mRNA and protein expression of CDK7 and its essential co-factors cyclinH and MAT1, were evaluated in breast cancer samples to determine if their levels are altered in cancer. Immunohistochemical staining of >900 breast cancers was used to determine the association with clinicopathological features and patient outcome. RESULTS: We show that expression of CDK7, cyclinH and MAT1 are all closely linked at the mRNA and protein level and their expression is elevated in breast cancer compared with the normal breast tissue. Intriguingly, CDK7 expression was inversely proportional to tumour grade and size and outcome analysis showed an association between CAK levels and better outcome. Moreover, CDK7 expression was positively associated with ERalpha expression and in particular with phosphorylation of ERalpha at serine 118, a site important for ERalpha transcriptional activity. CONCLUSIONS: Expression of components of the CAK complex, CDK7, MAT1 and Cyclin H are elevated in breast cancer and correlates with ERalpha.. Like ERalpha, CDK7 expression is inversely proportional to poor prognostic factors and survival.
AU - Patel,H
AU - Abduljabbar,R
AU - Lai,CF
AU - Periyasamy,M
AU - Harrod,A
AU - Gemma,C
AU - Steel,J
AU - Patel,N
AU - Busonero,C
AU - Jerjees,D
AU - Remenyi,J
AU - Smith,S
AU - Gomm,JJ
AU - Magnani,L
AU - Gyorffy,B
AU - Jones,JL
AU - Fuller-Pace,FV
AU - Shousha,S
AU - Buluwela,L
AU - Rakha,EA
AU - Ellis,IO
AU - Coombes,RC
AU - Ali,S
DO - 10.1158/1078-0432.CCR-15-1104
EP - 5938
PY - 2016///
SN - 1557-3265
SP - 5929
TI - CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer
T2 - Clinical Cancer Research
UR - http://dx.doi.org/10.1158/1078-0432.CCR-15-1104
UR - http://www.ncbi.nlm.nih.gov/pubmed/27301701
UR - http://hdl.handle.net/10044/1/33430
VL - 22
ER -